Literature DB >> 28601295

B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro.

Robert P Lisak1, Liljana Nedelkoska2, Joyce A Benjamins3, Dana Schalk4, Beverly Bealmear5, Hanane Touil6, Rui Li7, Gillian Muirhead8, Amit Bar-Or9.   

Abstract

B cells mediate multiple sclerosis (MS) pathogenesis by mechanisms unrelated to immunoglobulin (Ig). We reported that supernatants (Sup) from cultured B cells from blood of relapsing remitting MS (RRMS) patients, but not normal controls (NC), were cytotoxic to rat oligodendrocytes (OL). We now show that RRMS blood B cells, not stimulated in vitro, secrete factor/s toxic to rat and human neurons. Cytotoxicity is independent of Ig and multiple cytokines, not complement-mediated, and involves apoptosis. The factor/s have an apparent mw of >300kDa. B cells could contribute to damage within the central nervous system by secreting molecules toxic to OL and neurons.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  B cells; Cell death; Cytokines; Multiple sclerosis; Neurons; Oligodendrocytes

Mesh:

Year:  2017        PMID: 28601295     DOI: 10.1016/j.jneuroim.2017.05.004

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  37 in total

Review 1.  Multiple sclerosis.

Authors:  Massimo Filippi; Amit Bar-Or; Fredrik Piehl; Paolo Preziosa; Alessandra Solari; Sandra Vukusic; Maria A Rocca
Journal:  Nat Rev Dis Primers       Date:  2018-11-08       Impact factor: 52.329

2.  Potential Biomarker and Therapeutic LncRNAs in Multiple Sclerosis Through Targeting Memory B Cells.

Authors:  Elahe Ghoveud; Shohreh Teimuri; Jafar Vatandoost; Aref Hosseini; Kamran Ghaedi; Masood Etemadifar; Mohammad Hossein Nasr Esfahani; Timothy L Megraw
Journal:  Neuromolecular Med       Date:  2019-10-01       Impact factor: 3.843

3.  Trial of intrathecal rituximab in progressive multiple sclerosis patients with evidence of leptomeningeal contrast enhancement.

Authors:  Pavan Bhargava; Cassie Wicken; Matthew D Smith; Roy E Strowd; Irene Cortese; Daniel S Reich; Peter A Calabresi; Ellen M Mowry
Journal:  Mult Scler Relat Disord       Date:  2019-02-11       Impact factor: 4.339

Review 4.  The Multiple Roles of B Cells in Multiple Sclerosis and Their Implications in Multiple Sclerosis Therapies.

Authors:  Rui Li; Amit Bar-Or
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

Review 5.  Multiple Sclerosis: B Cells Take Center Stage.

Authors:  Anne-Katrin Pröbstel; Stephen L Hauser
Journal:  J Neuroophthalmol       Date:  2018-06       Impact factor: 3.042

Review 6.  The immunology of multiple sclerosis.

Authors:  Kathrine E Attfield; Lise Torp Jensen; Max Kaufmann; Manuel A Friese; Lars Fugger
Journal:  Nat Rev Immunol       Date:  2022-05-04       Impact factor: 53.106

Review 7.  The role of B cells in the immunopathogenesis of multiple sclerosis.

Authors:  Tohid Gharibi; Zohreh Babaloo; Arezoo Hosseini; Faroogh Marofi; Abbas Ebrahimi-Kalan; Saeed Jahandideh; Behzad Baradaran
Journal:  Immunology       Date:  2020-05-10       Impact factor: 7.397

Review 8.  Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview.

Authors:  Floriana De Angelis; Domenico Plantone; Jeremy Chataway
Journal:  CNS Drugs       Date:  2018-06       Impact factor: 5.749

Review 9.  B cells in autoimmune and neurodegenerative central nervous system diseases.

Authors:  Joseph J Sabatino; Anne-Katrin Pröbstel; Scott S Zamvil
Journal:  Nat Rev Neurosci       Date:  2019-11-11       Impact factor: 34.870

Review 10.  Role of B Cells in Multiple Sclerosis and Related Disorders.

Authors:  Giancarlo Comi; Amit Bar-Or; Hans Lassmann; Antonio Uccelli; Hans-Peter Hartung; Xavier Montalban; Per Solberg Sørensen; Reinhard Hohlfeld; Stephen L Hauser
Journal:  Ann Neurol       Date:  2020-11-04       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.